Lazard Asset Management’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.9M Sell
275,693
-65,706
-19% -$5.57M 0.04% 310
2026
Q1
$28.5M Sell
341,399
-9,893
-3% -$812K 0.05% 271
2025
Q4
$32.2M Sell
351,292
-19,631
-5% -$1.88M 0.05% 250
2025
Q3
$35.2M Sell
370,923
-16,878
-4% -$1.59M 0.05% 230
2025
Q2
$40.6M Buy
387,801
+2,431
+0.6% +$230K 0.06% 253
2025
Q1
$34.1M Buy
+385,370
New +$39.5M 0.05% 242
2024
Q4
Sell
-11,156
Closed -$913K 2386
2024
Q3
$913K Buy
11,156
+10,152
+1,011% +$783K ﹤0.01% 1115
2024
Q2
$86K Buy
1,004
+455
+83% +$36.8K ﹤0.01% 1793
2024
Q1
$44K Hold
549
﹤0.01% 1740
2023
Q4
$36K Hold
549
﹤0.01% 1979
2023
Q3
$40K Buy
549
+297
+118% +$20.1K ﹤0.01% 1915
2023
Q2
$15K Buy
+252
New +$14.6K ﹤0.01% 2151
2021
Q4
Sell
-20,370
Closed -$1.32M 2360
2021
Q3
$1.32M Buy
+20,370
New +$1.41M ﹤0.01% 997

Other funds holding HQY

Lazard Asset Management's HQY Position: Q2 2026 in Review

Lazard Asset Management reduced its HealthEquity (HQY) stake by 19% in Q2 2026, selling an estimated $5.57M and leaving 275,693 shares worth $24.9M. The position accounts for 0.04% of the portfolio, ranked #310.

Lazard Asset Management first reported a position in HQY in Q3 2021 and has held it in 13 quarters since. The position peaked at $40.6M in Q2 2025. 500 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Lazard Asset Management held 275,693 shares of HealthEquity worth $24.9M as of Q2 2026.
  • Lazard Asset Management sold 65,706 HealthEquity shares in Q2 2026, an estimated $5.57M.
  • HealthEquity made up 0.04% of Lazard Asset Management's portfolio in Q2 2026, its #310 holding.
  • Lazard Asset Management first reported a position in HealthEquity in Q3 2021 and has held it in 13 quarters since.
  • Lazard Asset Management's HealthEquity position peaked at $40.6M in Q2 2025.
  • 500 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.